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1607-551X/Copyright ª 2014, KaohsiuAbstract Limited reports are available in the literature on the impact of intravenous admin-
istration of anesthetics on laryngeal electromyographic (EMG) activity. The purpose of this
study was to determine the influence of the two commonly used intravenous anesthetics (pro-
pofol and thiamylal) on EMG amplitude evoked from the recurrent laryngeal nerve (RLN) during
thyroid surgery. A total of 40 patients were randomized to receive a bolus of propofol (0.5 mg/
kg; n Z 20) or thiamylal (1.5 mg/kg; n Z 20) to increase anesthetic depth when the surgeon
found patient movement intraoperatively. Evoked potentials were obtained before and every
1 minute after the administration of each agent for up to 5 minutes by stimulating the RLN. The
magnitude of evoked potentials at each time point and hemodynamic response were compared
within groups. The mean amplitude of evoked potentials did not change significantly after
administration of either propofol or thiamylal (p > 0.05 within groups). Mean arterial pressure
measured from 1 minute to 5 minutes was significantly lower in the propofol group than in theeclare no conflicts of interest.
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500 P.-Y. Chang et al.thiamylal group (p < 0.05). Heart rate measured within 5 minutes did not differ significantly
within groups. Low dose of propofol (0.5 mg/kg) or thiamylal (1.5 mg/kg) did not affect
EMG readings during neuromonitoring of the RLN in thyroid surgery. Our results show that thia-
mylal provides better hemodynamic stability than propofol, and is therefore a preferable
agent to increase anesthesia depth and prevent further patient movement during intraopera-
tive neuromonitoring.
Copyright ª 2014, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Table 1 Comparison of patient characteristics between
the two groups.
Propofol
group (n Z 20)
Thiamylal
group (n Z 20)
p
Sex (M:F) 2:18 5:15 0.21
Age (y) 47.3  9.4 50.8  16.4 0.42
Weight (kg) 59.7  12.9 63.1  12.7 0.41
Height (cm) 159.8  7.9 161.1  9.3 0.63
Disease 0.73
Benign goiter 14 (70) 13 (65)
Carcinoma 6 (30) 7 (35)
Procedure 0.74
Total lobectomy 13 (70) 12 (70)
Total thyroidectomy 7 (30) 8 (30)
Data are presented as mean  standard deviation or n (%).Introduction
Intraoperative neuromonitoring (IONM) during thyroid and
parathyroid operation has gained increased popularity to
assist in nerve identification and dissection, detection of
lesion site, and prediction of postoperative vocal cord
function [1e8]. However, the use of intravenous or inha-
lational anesthetics can be a potential factor that would
interfere with the reading of neuromonitoring signals.
Therefore, many modern operations with a neuro-
monitoring technique such as thyroid, spine, or cranial
surgery have exercised additional caution on the adminis-
tration of general anesthesia [9,10]. Titration of anesthetic
agents is necessary to adjust anesthetic depth for various
situations and allow for a satisfactory monitoring signal
while keeping the patient sufficiently anesthetized. Stan-
dard general anesthesia with endotracheal tube commonly
includes opioids, intravenous anesthetics, neuromuscular
blocking agents (NMBAs) for anesthesia induction, and
inhalational anesthetics for anesthesia maintenance. The
use of NMBA has been well-known to diminish the evoked
potential and reduce sensitivity to impending neural injury;
therefore, a titration of NMBA dosage for anesthetic in-
duction and avoiding administration of NMBA throughout
the remaining period of the operation had been suggested
[11e13]. The depth of anesthesia may be lighter under
anesthesia maintenance without using NMBA. Because the
depth of anesthesia is light enough, spontaneous activity of
vocal cords may occur with patient movement. Under this
circumstance, additional intravenous anesthetics (propofol
or thiamylal) are commonly used to prevent further patient
movement. However, only a few studies are available
concerning the impact of intravenous anesthetics on
laryngeal electromyographic (EMG) activity. This study
aimed to determine the influence of the two commonly
used intravenous anesthetics (propofol and thiamylal) on
EMG amplitude evoked from the recurrent laryngeal nerve
(RLN) during thyroid surgery.
Materials and methods
We recruited 40 consecutive adult patients (including 7
men and 33 women; age range, 17e83 years) scheduled to
receive a thyroid operation with IONM from July 2011 to
January 2012. All of these 40 patients underwent opera-
tions for various thyroid diseases. The inclusion criterion
was intraoperative patient movement requiring a bolus ofintravenous anesthetics to stop further movement. Exclu-
sion criteria were anticipated difficult intubation, severe
liver or renal function impairment, asthma, drug abuse, and
morbid obesity.
The anesthesia team included two experienced anes-
thesiologists and one fixed nurse anesthetist for anesthetic
care and recording. General anesthesia was induced with
fentanyl (2 mg/kg) and thiopental (5 mg/kg), and a single
dose (0.3 mg/kg) of rocuronium was administered to facil-
itate EMG endotracheal tube insertion. When maximal
neuromuscular blockade was achieved, another bolus of
propofol (50 mg) was given. A Medtronic Xomed NIM stan-
dard EMG endotracheal tube (Jacksonville, FL, USA) was
then inserted by an experienced anesthesiologist under
direct laryngoscopy. A 6.0-mm EMG endotracheal tube was
used for women, whereas a 7.0-mm tube was used for men.
The tube was placed with the middle of the exposed
electrodes in contact with the true vocal cords under direct
laryngoscopy. After successful tracheal intubation, general
anesthesia was maintained with 2e4% sevoflurane. The
position of electrodes was routinely checked by laryngo-
fiberoscopic examination immediately after intubation and
after the patient’s neck was placed at full extension for
performing standardized IONM procedures [14,15]. The
electrodes from the NIM EMG endotracheal tube were
connected to an NIM-Response 3.0 monitor (Medtronic
Xomed). The event threshold was set at 100 mV and an
activated evoked potential greater than 100 mV was
considered as a positive EMG signal.
Table 2 Comparison of mean EMG amplitude changes after a bolus of intravenous anesthetics within groups.a
Time (min) 0 1 2 3 4 5
Propofol (n Z 20) 1239  651 1250  643 1252  643 1244  632 1281  653 1258  644
Thiamylal (n Z 20) 1483  690 1494  724 1479  734 1500  712 1494  709 1509  696
Data are presented as mean  SD.
0 min Z baseline prior to injection; EMG Z electromyography; time Z minutes after injection of a bolus of intravenous anesthetics.
a No significant difference in EMG amplitudes was found after a bolus of intravenous anesthetics within both groups.
Intravenous anesthetics on neuromonitoring 501All patients were treated by the same surgeon (F.Y.C.).
When the surgeon found spontaneous vocal cords activities
with noisy EMG signal during the operation, a bolus of
propofol (0.5 mg/kg, n Z 20) or thiamylal (1.5 mg/kg,
nZ 20) was given to increase anesthetic depth and prevent
further patient movement. Patients were randomly
assigned to receive either propofol or thiamylal using a
computer-generated table of random numbers. The RLN
was stimulated before and every 1 minute after the
administration of an extra bolus of propofol or thiamylal for
5 minutes. The magnitude of evoked potentials at each
time point and hemodynamic response [heart rates (HRs)
and mean arterial pressure (MAP)] were recorded and
compared within groups. Complete IONM data of 40 pa-
tients who had normal cord mobility documented with a
video laryngo fiberscope pre- and postoperatively were
recorded and analyzed. Statistical analysis of continuous
variables between groups was compared using two-sample t
test. Statistical analysis of continuous variables within
groups was compared using paired t test. Categorical
nominal variables were analyzed with Chi-square or Fisher’s
exact tests. All statistical tests were two tailed and
p < 0.05 was considered statistically significant. All data
were expressed as mean  standard deviation.
The study was registered in the ClinicalTrials.gov
(http://www.clinicaltrials.gov, identifier: NCT00629746).
Patients were informed of the intent to use this monitoring
system to potentially aid other surgeons in the localization
and identification of the RLNs, and for the assessment of
their function during operation.Figure 1. Comparison of mean arterial pressure (MAP) after
intravenous anesthetics.Results
A comparison of patient characteristics between the two
groups is demonstrated in Table 1. Age, sex, and types of
disease did not differ significantly between the two groups.
The mean EMG amplitude did not change significantly from
baseline to 5 minutes after administration of either pro-
pofol or thiamylal (p > 0.05 within groups; Table 2). After
an extra bolus of intravenous anesthetics, no patient
developed further movement. Baseline hemodynamic con-
ditions (MAP and HR) were similar between groups. MAP
measured from 1 minute to 5 minutes was significantly
lower in the propofol group than in the thiamylal group
(p < 0.05; Fig. 1). HR measured from baseline to 5 minutes
after intravenous anesthetics injection did not differ
significantly within groups (Table 3).Discussion
Our main results revealed that the mean amplitude of
evoked potentials did not change significantly before and
after administration of each agent. An extra bolus of either
propofol or thiamylal is our routine to rapidly titrate
anesthesia level during IONM. In our anesthesia protocol for
neuromonitoring, only a single dose of NMBA (rocuronium
0.3 mg/kg) is given at the induction of general anesthesia.
The depth of anesthesia is mainly maintained by inhala-
tional anesthetics (sevoflurane 2e4%) after NMBA wear off.
If the depth of anesthesia is not sufficient to suppress
spontaneous activity of vocal cords, patients might develop
further movement such as coughing, bucking, or movement
of the limbs. A bolus of NMBA is usually the first choice to
prevent patient movement but should be avoided during
IONM. Although increasing the concentration of inhalational
anesthetics is effective, it takes a longer time to produce
the adequate effect; therefore, an extra bolus of short-
acting intravenous anesthetics would be an optimal choice
in these cases.
Propofol, the most commonly used intravenous anes-
thetic, is an alkylphenol presently formulated in a lipid
emulsion. Propofol provides rapid onset and offset and is
used for the induction and maintenance of general anes-
thesia [16,17]. We found that a single small dose of pro-
pofol did not alter evoked potential from the RLN during
thyroid surgery. During spine surgery, propofol has been
reported to produce a dose-dependent reduction in the
amplitude of motor evoked potentials without an effect on
the latency [18]. Savoia et al. [19] reported that the la-
tency and amplitude of cortical middle latency auditory
potentials were prolonged and decreased, respectively, in a
Table 3 Comparison of heart rate changes after a bolus of intravenous anesthetics within groups.a
Time (min) 0 1 2 3 4 5
Propofol (n Z 20) 82.3  9.3 81.7  9.4 81.3  9.3 81.3  9.6 81.5  9.5 81.7  9.2
Thiamylal (n Z 20) 77.8  13.2 78.9  12.7 77.4  13.3 76.8  13.4 76.2  13.7 76.2  13.8
Data are presented as mean  SD.
0 min Z baseline prior to injection; time Z minutes after injection of a bolus of intravenous anesthetics.
a No significant difference in heart rate was found after a bolus of intravenous anesthetics within both groups.
502 P.-Y. Chang et al.dose-related manner. However, propofol has no effect on
brain stem auditory-evoked potentials under regular
maintenance dose [19].
Barbiturates are used clinically for anesthesia induction
and maintenance. Thiamylal, an ultrashort-acting barbitu-
rate, provides rapid onset and offset when used as a single
dose, but prolonged administration will accumulate rapidly,
leading to slow recovery [20]. Thiamylal is similar to pro-
pofol in increasing anesthesia depth without altering the
IONM reading. Furthermore, thiamylal demonstrates a
better hemodynamic profile than propofol with a lesser
extent of a decrease in MAP. Cardiovascular depression
produced by barbiturates is a result of dose-related nega-
tive inotropic action and peripheral vasodilatation, which
leads to a slightly reduced MAP and an increase in HR [21].
In our study, the dose of thiamylal was relatively small and
did not reveal significant cardiovascular depression. Not
surprisingly, patients receiving propofol demonstrated the
typical effect, that is, a decrease in arterial blood pressure.
Conclusion
In this study, a low dose of propofol (0.5 mg/kg) or thia-
mylal (1.5 mg/kg) did not affect readings of EMG signal
during IONM of the RLN in thyroid surgery. However, thia-
mylal provided better hemodynamic stability than propo-
fol. Thus, we conclude that thiamylal is a preferable agent
to increase anesthesia depth and prevent further patient
movement during IONM.Acknowledgments
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